In both the 1L and 2L settings, a higher proportion of patients with KRAS G12C–positive tumors were female, were former or current smokers, and had tumors with a higher proportion of PD-L1–high and non-squamous histology than patients with KRAS WT cancer (Table 1). The gene discussed is KRAS; the disease is cancer.